HEADER VIRAL PROTEIN 24-MAR-16 5IYR TITLE PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 IN COMPLEX WITH 2- TITLE 2 FUCOSYLLACTOSE (2'FL) COMPND MOL_ID: 1; COMPND 2 MOLECULE: GII.4 NOROVIRUS CHDC2094 CAPSID; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PROTRUDING DOMAIN (UNP RESIDUES 225-530); COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NOROVIRUS HU/GII.4/CHDC2094/1974/US; SOURCE 3 ORGANISM_TAXID: 660656; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: MBP-HTSHP KEYWDS VIRAL CAPSID PROTEIN, PROTRUDING DOMAIN, VIRAL PROTEIN, NOROVIRUS, KEYWDS 2 HUMAN MILK OLIGOSACCHARIDES EXPDTA X-RAY DIFFRACTION AUTHOR B.K.SINGH,G.S.HANSMAN REVDAT 3 10-JAN-24 5IYR 1 HETSYN LINK REVDAT 2 29-JUL-20 5IYR 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE ATOM REVDAT 1 05-APR-17 5IYR 0 JRNL AUTH B.K.SINGH,G.S.HANSMAN JRNL TITL STRUCTURAL BASIS FOR GII.4 NOROVIRUS INHIBITION BY HUMAN JRNL TITL 2 MILK OLIGOSACCHARIDES. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.44 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 94289 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.138 REMARK 3 R VALUE (WORKING SET) : 0.136 REMARK 3 FREE R VALUE : 0.170 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4716 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.4538 - 4.7831 0.99 3237 171 0.1339 0.1517 REMARK 3 2 4.7831 - 3.7972 0.99 3113 164 0.1227 0.1460 REMARK 3 3 3.7972 - 3.3174 0.98 3042 160 0.1454 0.1678 REMARK 3 4 3.3174 - 3.0142 0.99 3069 161 0.1451 0.1442 REMARK 3 5 3.0142 - 2.7982 0.99 3044 161 0.1495 0.1882 REMARK 3 6 2.7982 - 2.6332 0.99 3027 159 0.1436 0.1970 REMARK 3 7 2.6332 - 2.5014 0.99 3038 160 0.1392 0.1830 REMARK 3 8 2.5014 - 2.3925 0.99 3024 159 0.1331 0.1527 REMARK 3 9 2.3925 - 2.3004 0.99 3024 159 0.1292 0.1656 REMARK 3 10 2.3004 - 2.2210 0.98 2990 158 0.1462 0.1941 REMARK 3 11 2.2210 - 2.1516 0.99 3006 158 0.1347 0.1730 REMARK 3 12 2.1516 - 2.0901 0.98 2998 158 0.1312 0.1536 REMARK 3 13 2.0901 - 2.0351 0.97 2950 155 0.1382 0.1728 REMARK 3 14 2.0351 - 1.9854 0.98 2961 156 0.1326 0.1460 REMARK 3 15 1.9854 - 1.9403 0.98 2981 156 0.1362 0.1750 REMARK 3 16 1.9403 - 1.8990 0.97 2962 157 0.1645 0.2219 REMARK 3 17 1.8990 - 1.8610 0.98 2951 155 0.1338 0.1797 REMARK 3 18 1.8610 - 1.8259 0.98 2974 157 0.1246 0.1821 REMARK 3 19 1.8259 - 1.7933 0.98 2944 155 0.1159 0.1549 REMARK 3 20 1.7933 - 1.7629 0.97 2926 153 0.1165 0.1657 REMARK 3 21 1.7629 - 1.7344 0.98 2987 158 0.1135 0.1803 REMARK 3 22 1.7344 - 1.7077 0.97 2913 153 0.1200 0.1789 REMARK 3 23 1.7077 - 1.6826 0.97 2965 156 0.1211 0.1658 REMARK 3 24 1.6826 - 1.6589 0.97 2933 155 0.1229 0.1975 REMARK 3 25 1.6589 - 1.6365 0.97 2936 154 0.1250 0.1792 REMARK 3 26 1.6365 - 1.6153 0.97 2917 154 0.1347 0.1750 REMARK 3 27 1.6153 - 1.5951 0.96 2897 152 0.1409 0.1944 REMARK 3 28 1.5951 - 1.5758 0.97 2970 156 0.1459 0.1984 REMARK 3 29 1.5758 - 1.5575 0.97 2892 153 0.1601 0.2003 REMARK 3 30 1.5575 - 1.5400 0.96 2902 153 0.1859 0.2629 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 14.760 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.02 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4977 REMARK 3 ANGLE : 1.219 6829 REMARK 3 CHIRALITY : 0.049 775 REMARK 3 PLANARITY : 0.007 895 REMARK 3 DIHEDRAL : 12.699 1793 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5IYR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-MAR-16. REMARK 100 THE DEPOSITION ID IS D_1000219664. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : SI111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 96406 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.530 REMARK 200 RESOLUTION RANGE LOW (A) : 43.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.14300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.6300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.53 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.57 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.76000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.580 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6, PHASER REMARK 200 STARTING MODEL: 5IYN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE, PEG3350, PH 5.6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 45.14500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 53.23500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 67.73500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 45.14500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 53.23500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 67.73500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 45.14500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 53.23500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 67.73500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 45.14500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 53.23500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 67.73500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B1083 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 224 REMARK 465 ASP A 393 REMARK 465 HIS A 394 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 483 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 523 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 315 CG CD OE1 OE2 REMARK 470 ARG B 483 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 702 O HOH B 883 1.98 REMARK 500 O3 GLC C 1 O HOH A 701 2.04 REMARK 500 OD2 ASP B 370 O HOH B 701 2.08 REMARK 500 OD2 ASP A 370 O HOH A 702 2.09 REMARK 500 O1 GLC C 1 O HOH A 703 2.13 REMARK 500 OD1 ASN B 310 O HOH B 702 2.13 REMARK 500 O HOH A 795 O HOH A 862 2.14 REMARK 500 O4 GLC C 1 O5 GAL C 2 2.15 REMARK 500 OD1 ASP A 289 O HOH A 704 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 714 O HOH B 781 3555 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 254 23.98 -141.48 REMARK 500 GLN A 260 51.69 -142.41 REMARK 500 ASN A 373 -8.75 -160.33 REMARK 500 SER A 441 145.12 -179.37 REMARK 500 THR A 481 -6.53 -142.85 REMARK 500 THR A 481 -11.57 -140.48 REMARK 500 ASN A 521 -162.90 -71.48 REMARK 500 PHE B 242 145.91 -170.76 REMARK 500 ASN B 373 -12.51 -152.71 REMARK 500 SER B 441 147.03 179.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1073 DISTANCE = 6.18 ANGSTROMS REMARK 525 HOH A1074 DISTANCE = 6.65 ANGSTROMS REMARK 525 HOH B1085 DISTANCE = 6.17 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5IYQ RELATED DB: PDB REMARK 900 PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 IN COMPLEX WITH REMARK 900 HBGA TYPE B (TRIGLYCAN) REMARK 900 RELATED ID: 5IYP RELATED DB: PDB REMARK 900 PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 IN COMPLEX WITH REMARK 900 HBGA TYPEA (TRIGLYCAN) REMARK 900 RELATED ID: 5IYN RELATED DB: PDB REMARK 900 PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 REMARK 900 RELATED ID: 5HZB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GII.10 P DOMAIN IN COMPLEX WITH 2- REMARK 900 FUCOSYLLACTOSE (2'FL) DBREF 5IYR A 225 529 UNP D0QJ68 D0QJ68_9CALI 225 529 DBREF 5IYR B 225 529 UNP D0QJ68 D0QJ68_9CALI 225 529 SEQADV 5IYR SER A 224 UNP D0QJ68 EXPRESSION TAG SEQADV 5IYR SER B 224 UNP D0QJ68 EXPRESSION TAG SEQRES 1 A 306 SER LYS PRO PHE THR VAL PRO ILE LEU THR VAL GLU GLU SEQRES 2 A 306 MET SER ASN SER ARG PHE PRO ILE PRO LEU GLU LYS LEU SEQRES 3 A 306 TYR THR GLY PRO SER SER ALA PHE VAL VAL GLN PRO GLN SEQRES 4 A 306 ASN GLY ARG CYS THR THR ASP GLY VAL LEU LEU GLY THR SEQRES 5 A 306 THR GLN LEU SER ALA VAL ASN ILE CYS ASN PHE ARG GLY SEQRES 6 A 306 ASP VAL THR ARG VAL GLY ILE SER HIS ASP TYR THR MET SEQRES 7 A 306 ASN LEU VAL SER GLN ASN TRP ASN ASN TYR ASP PRO THR SEQRES 8 A 306 GLU GLU ILE PRO ALA PRO LEU GLY THR PRO ASP PHE VAL SEQRES 9 A 306 GLY LYS ILE GLN GLY LEU LEU THR GLN THR THR ARG ALA SEQRES 10 A 306 ASP GLY SER THR ARG ALA HIS LYS ALA THR VAL SER THR SEQRES 11 A 306 GLY SER VAL HIS PHE THR PRO LYS LEU GLY SER VAL GLN SEQRES 12 A 306 PHE THR THR ASP THR ASN ASN ASP PHE GLN THR GLY GLN SEQRES 13 A 306 ASN THR LYS PHE THR PRO VAL GLY VAL ILE GLN ASP GLY SEQRES 14 A 306 ASP HIS HIS GLN ASN GLU PRO GLN GLN TRP VAL LEU PRO SEQRES 15 A 306 ASN TYR SER GLY THR SER GLY HIS ASN VAL HIS LEU ALA SEQRES 16 A 306 PRO ALA VAL ALA PRO THR PHE PRO GLY GLU GLN LEU LEU SEQRES 17 A 306 PHE PHE ARG SER THR MET PRO GLY CYS SER GLY TYR PRO SEQRES 18 A 306 ASN MET ASN LEU ASP CYS LEU LEU PRO GLN GLU TRP VAL SEQRES 19 A 306 SER HIS PHE TYR GLN GLU ALA ALA PRO ALA GLN SER ASP SEQRES 20 A 306 VAL ALA LEU LEU ARG PHE VAL ASN PRO ASP THR GLY ARG SEQRES 21 A 306 VAL LEU PHE GLU CYS LYS LEU HIS LYS SER GLY TYR ILE SEQRES 22 A 306 THR VAL ALA HIS THR GLY PRO TYR ASP LEU VAL ILE PRO SEQRES 23 A 306 PRO ASN GLY TYR PHE ARG PHE ASP SER TRP VAL ASN GLN SEQRES 24 A 306 PHE TYR THR LEU ALA PRO MET SEQRES 1 B 306 SER LYS PRO PHE THR VAL PRO ILE LEU THR VAL GLU GLU SEQRES 2 B 306 MET SER ASN SER ARG PHE PRO ILE PRO LEU GLU LYS LEU SEQRES 3 B 306 TYR THR GLY PRO SER SER ALA PHE VAL VAL GLN PRO GLN SEQRES 4 B 306 ASN GLY ARG CYS THR THR ASP GLY VAL LEU LEU GLY THR SEQRES 5 B 306 THR GLN LEU SER ALA VAL ASN ILE CYS ASN PHE ARG GLY SEQRES 6 B 306 ASP VAL THR ARG VAL GLY ILE SER HIS ASP TYR THR MET SEQRES 7 B 306 ASN LEU VAL SER GLN ASN TRP ASN ASN TYR ASP PRO THR SEQRES 8 B 306 GLU GLU ILE PRO ALA PRO LEU GLY THR PRO ASP PHE VAL SEQRES 9 B 306 GLY LYS ILE GLN GLY LEU LEU THR GLN THR THR ARG ALA SEQRES 10 B 306 ASP GLY SER THR ARG ALA HIS LYS ALA THR VAL SER THR SEQRES 11 B 306 GLY SER VAL HIS PHE THR PRO LYS LEU GLY SER VAL GLN SEQRES 12 B 306 PHE THR THR ASP THR ASN ASN ASP PHE GLN THR GLY GLN SEQRES 13 B 306 ASN THR LYS PHE THR PRO VAL GLY VAL ILE GLN ASP GLY SEQRES 14 B 306 ASP HIS HIS GLN ASN GLU PRO GLN GLN TRP VAL LEU PRO SEQRES 15 B 306 ASN TYR SER GLY THR SER GLY HIS ASN VAL HIS LEU ALA SEQRES 16 B 306 PRO ALA VAL ALA PRO THR PHE PRO GLY GLU GLN LEU LEU SEQRES 17 B 306 PHE PHE ARG SER THR MET PRO GLY CYS SER GLY TYR PRO SEQRES 18 B 306 ASN MET ASN LEU ASP CYS LEU LEU PRO GLN GLU TRP VAL SEQRES 19 B 306 SER HIS PHE TYR GLN GLU ALA ALA PRO ALA GLN SER ASP SEQRES 20 B 306 VAL ALA LEU LEU ARG PHE VAL ASN PRO ASP THR GLY ARG SEQRES 21 B 306 VAL LEU PHE GLU CYS LYS LEU HIS LYS SER GLY TYR ILE SEQRES 22 B 306 THR VAL ALA HIS THR GLY PRO TYR ASP LEU VAL ILE PRO SEQRES 23 B 306 PRO ASN GLY TYR PHE ARG PHE ASP SER TRP VAL ASN GLN SEQRES 24 B 306 PHE TYR THR LEU ALA PRO MET HET GLC C 1 12 HET GAL C 2 11 HET FUC C 3 10 HET GLC D 1 12 HET GAL D 2 11 HET FUC D 3 10 HET FLC B 604 13 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM FLC CITRATE ANION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 3 GLC 2(C6 H12 O6) FORMUL 3 GAL 2(C6 H12 O6) FORMUL 3 FUC 2(C6 H12 O5) FORMUL 5 FLC C6 H5 O7 3- FORMUL 6 HOH *759(H2 O) HELIX 1 AA1 THR A 233 MET A 237 5 5 HELIX 2 AA2 SER A 279 ILE A 283 5 5 HELIX 3 AA3 THR A 359 LEU A 362 5 4 HELIX 4 AA4 SER A 408 GLY A 412 5 5 HELIX 5 AA5 PRO A 453 ALA A 464 1 12 HELIX 6 AA6 THR B 233 MET B 237 5 5 HELIX 7 AA7 SER B 279 ILE B 283 5 5 HELIX 8 AA8 THR B 359 LEU B 362 5 4 HELIX 9 AA9 SER B 408 GLY B 412 5 5 HELIX 10 AB1 PRO B 453 ALA B 464 1 12 SHEET 1 A 3 LYS A 248 THR A 251 0 SHEET 2 A 3 LEU A 431 THR A 436 -1 SHEET 3 A 3 ASN A 447 CYS A 450 -1 SHEET 1 B 6 SER A 364 THR A 368 0 SHEET 2 B 6 ASP A 298 LEU A 303 -1 SHEET 3 B 6 PHE A 286 ARG A 292 -1 SHEET 4 B 6 THR A 381 ILE A 389 -1 SHEET 5 B 6 LYS A 329 THR A 337 -1 SHEET 6 B 6 THR A 344 SER A 352 -1 SHEET 1 C 5 GLU A 428 LEU A 430 0 SHEET 2 C 5 TYR A 495 ALA A 499 -1 SHEET 3 C 5 ARG A 483 HIS A 491 -1 SHEET 4 C 5 VAL A 471 ASN A 478 -1 SHEET 5 C 5 TYR A 513 VAL A 520 -1 SHEET 1 D 2 GLY A 387 ILE A 389 0 SHEET 2 D 2 PRO A 438 SER A 441 1 SHEET 1 E 3 LYS B 248 THR B 251 0 SHEET 2 E 3 LEU B 431 THR B 436 -1 SHEET 3 E 3 ASN B 447 CYS B 450 -1 SHEET 1 F 6 SER B 364 THR B 368 0 SHEET 2 F 6 ASP B 298 LEU B 303 -1 SHEET 3 F 6 PHE B 286 ARG B 292 -1 SHEET 4 F 6 THR B 381 VAL B 388 -1 SHEET 5 F 6 LYS B 329 THR B 337 -1 SHEET 6 F 6 THR B 344 SER B 352 -1 SHEET 1 G 5 GLU B 428 LEU B 430 0 SHEET 2 G 5 TYR B 495 ALA B 499 -1 SHEET 3 G 5 VAL B 484 HIS B 491 -1 SHEET 4 G 5 VAL B 471 VAL B 477 -1 SHEET 5 G 5 TYR B 513 VAL B 520 -1 SHEET 1 H 2 GLY B 387 ILE B 389 0 SHEET 2 H 2 PRO B 438 SER B 441 1 LINK O4 GLC C 1 C1 GAL C 2 1555 1555 1.42 LINK O2 GAL C 2 C1 FUC C 3 1555 1555 1.43 LINK O4 GLC D 1 C1 GAL D 2 1555 1555 1.33 LINK O2 GAL D 2 C1 FUC D 3 1555 1555 1.43 CISPEP 1 GLU A 398 PRO A 399 0 -11.45 CISPEP 2 GLU B 398 PRO B 399 0 -6.85 CRYST1 90.290 106.470 135.470 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011075 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009392 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007382 0.00000